Your patients can sign up for regular tailored emails from Macmillan to support them through diagnosis and beyond. With information ranging from treatment to the impact of cancer on money and work, tell your patients to sign up today. Learn more here
Prostap® DCS (leuprorelin acetate)—a 3-monthly gonadotrophin-releasing hormone (GnRH) agonist treatment for breast cancer
Information intended for UK healthcare professionals only. This round-table discussion supplement has been commissioned and funded by Takeda UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
Date of preparation: April 2021
This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
Date of preparation: February 2021